Probiotc Lactobacillus Crispatus-M247 (Crispact®) Supplementation in the Sterilization of High-risk Human Papilloma (HPV-HR) Viruses
There is growing scientific interest in probiotic supplementation as a possible therapy for clearing the human papillomavirus (HPV) infection and reducing the risk of developement of cervical cancer.
Human Papillomavirus Infection
DIETARY_SUPPLEMENT: Crispact®|DIETARY_SUPPLEMENT: Placebo
Human papillomavirus (HPV) clearance, Testing negative for HPV, After 4-months|Changes in vaginal bacterial quantity (population) that colonize, called Community State Type (CST), Changes in vaginal microbiota, After 4-months
This is a multicenter, randomized, longitudinal, prospective, parallel-group, single-blind study aimed to investigate the efficacy of probiotic Crispact® (which contains: 20 Bld CFU/Stick of Lactobacillus crispatus M247) in clearance of human papillomavirus (HPV) infection in healthy female who tested positive for human papillomavirus (HPV) infection.